Vernal Biosciences launches as mRNA manufacturer

By The Science Advisory Board staff writers

Vernal Biosciences has launched as a new mRNA manufacturer, supported by a round of seed funding led by Alloy Therapeutics.

The new firm is based in Burlington, VT, and was founded by CEO Christian Cobaugh, who has previously worked on mRNA development at Omega Therapeutics, Translate Bio, Arcturus Therapeutics, and Alexion Pharmaceuticals. It plans to use the funding for its technical development and commercial operations.

Vernal currently offers manufacturing-research-use mRNA and is scaling its manufacturing process that will become an advanced staging ground for clinical manufacturing projects, it said.

Copyright © 2021

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?